Vincerx Pharma Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Vincerx Pharma's estimated annual revenue is currently $5.6M per year.(i)
  • Vincerx Pharma's estimated revenue per employee is $201,000

Employee Data

  • Vincerx Pharma has 28 Employees.(i)
  • Vincerx Pharma grew their employee count by -36% last year.

Vincerx Pharma's People

NameTitleEmail/Phone
1
VP BiometricsReveal Email/Phone
2
Head medicinal chemistryReveal Email/Phone
3
Head Target Discovery, non-clinical Biology, Pharmakology & DMPKReveal Email/Phone
4
SVP Clinical DevelopmentReveal Email/Phone
5
Senior Director Chemical DevelopmentReveal Email/Phone
6
Sr. Director Medical Safety SystemsReveal Email/Phone
7
Senior Director, Head Statistical ProgrammingReveal Email/Phone
8
Associate Director Clinical OperationsReveal Email/Phone
9
Director Clinical Programming and Data ScienceReveal Email/Phone
10
Senior Director, Informatics Support & QMS InfrastructureReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$102.7M51125%N/AN/A
#2
$0.4M20%N/AN/A
#3
$38.6M1923%N/AN/A
#4
$35M1272%$62.5MN/A
#5
$36.6M18218%N/AN/A
#6
$131.9M656-3%N/AN/A
#7
$133.5M664N/AN/AN/A
#8
$72.8M362-4%N/AN/A
#9
$551.9M1716-2%N/AN/A
#10
$11.7M5812%N/AN/A
Add Company

What Is Vincerx Pharma?

Vincerx is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer.

keywords:N/A

N/A

Total Funding

28

Number of Employees

$5.6M

Revenue (est)

-36%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vincerx Pharma News

2022-04-06 - Vincerx Pharma Highlights VIP152 Preclinical, Clinical Data In Gynecological Cancers - Benzinga

Vincerx Pharma Highlights VIP152 Preclinical, Clinical Data In Gynecological Cancers ... [TODAY ONLY] Get 50% OFF and get 2 bear market-beating...

2022-04-06 - Vincerx Pharma Presents Preclinical and Preliminary Clinical ...

Vincerx Pharma Presents Preclinical and Preliminary Clinical Data on PTEFb/CDK9 Inhibitor VIP152 in Gynecologic Malignancies at the American...

2022-03-30 - Vincerx Pharma Reports Fourth Quarter and Full Year 2021 ...

About Vincerx Pharma, Inc. Vincerx Pharma, Inc. (Vincerx) is a clinical-stage life sciences company focused on leveraging its extensive...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.5M2833%$13M
#2
$3.2M2875%N/A
#3
$1.7M284%N/A
#4
$7M280%N/A
#5
$2.8M288%N/A